The Recall Desk

Manufacturer

Hospira, Inc.

257 recalls in our database name Hospira, Inc. as the manufacturing or recalling firm.

What the numbers show

Total
257
Critical
18
Severe
104
Most recent
2017-05-31

Of the 257 recalls from Hospira, Inc. we have scored against our rubric, 18 (7%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 104 (40%) are Severe.

Which agencies issued them

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

51–75 of 257

  • LowFDA (Drugs)·D-0727-2016·2016-03-02

    Hospira Recalls Normosol-M Bags With Incorrect Expiration Date Labeling

    Hospira is recalling 10,778 bags of Normosol-M and 5% Dextrose Injection due to an incorrect expiration date printed on the primary container.

    Product
    Normosol-M and 5% Dextrose (multiple electrolytes and 5% dextrose) Injection Type 1, USP, 1000 mL Single-Dose Container bag, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7965-09, Barcode (01) 0 030409 796509 0.
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0668-2016·2016-02-24

    Hospira Recalls Magnesium Sulfate Injection Bags Due to Incorrect Barcode Labeling

    Hospira is recalling 213,600 bags of Magnesium Sulfate in Water for Injection because the primary bag labeling may be mislabeled with a barcode that scans as heparin sodium.

    Product
    MAGNESIUM SULFATE IN WATER — MAGNESIUM SULFATE IN WATER (MAGNESIUM SULFATE IN WATER)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0054-2016·2015-10-28

    Hospira Recalls Amidate Etomidate Injection Due to Degradation Impurities

    Hospira Inc. is recalling 24,100 syringes of Amidate (Etomidate Injection) because stability testing confirmed out-of-specification degradation products.

    Product
    Amidate (Etomidate Injection, USP), 40 mg/20 mL (2 mg/mL), LifeShield, 20 mL, Glass Abboject Syringe with male luer lock adapter, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-8060-29
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1815-2015·2015-09-30

    Hospira Recalls Lidocaine Hydrochloride Injection Due to Particulate Matter

    Hospira, Inc. is recalling Lidocaine Hydrochloride Injection vials because iron oxide particulate matter was found embedded in the glass vial necks.

    Product
    LIDOCAINE HYDROCHLORIDE — LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0418-2015·2015-09-23

    Hospira Recalls Ketamine Hydrochloride Injection Due to Cracked Vials

    Hospira is recalling 83,320 vials of Ketamine Hydrochloride Injection because customer complaints reported cracked and leaking glass vials.

    Product
    Ketamine Hydrochloride Injection, USP (100 mg/mL) packaged in 5 mL multi-dose glass fliptop vials, 10 vials per box, Rx only, Manufactured by: Hospira Inc., Lake Forest, IL 60045. NDC 00409-2051-05
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1240-2015·2015-07-22

    Hospira Recalls 0.9% Sodium Chloride Injection Due to Sterility Concerns

    Hospira is recalling 314,600 bags of 0.9% Sodium Chloride Injection USP due to potential channel leaks that may compromise sterility.

    Product
    0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira, Inc., Ausitn, TX 78728, NDC 00409-7101-68
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-1241-2015·2015-07-22

    Hospira Recalls Ketorolac Tromethamine Injections Due to Crystallization

    Hospira Inc. is recalling Ketorolac Tromethamine Injections because crystallization was identified as the calcium salt of Ketorolac.

    Product
    KETOROLAC TROMETHAMINE — KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1242-2015·2015-07-22

    Hospira Recalls Ketorolac Tromethamine Injections Due to Crystallization

    Hospira Inc. is recalling specific lots of Ketorolac Tromethamine Injection due to the presence of crystals identified as the calcium salt of Ketorolac.

    Product
    KETOROLAC TROMETHAMINE — KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1216-2015·2015-07-15

    Hospira Recalls Bupivacaine Hydrochloride Vials Due to Particulate Matter

    Hospira is recalling Bupivacaine Hydrochloride Injection vials because they contain free-floating and embedded iron oxide particles.

    Product
    BUPIVACAINE HYDROCHLORIDE — BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1232-2015·2015-07-15

    Hospira Recalls Magnesium Sulfate Injection Due to pH Specification Failure

    Hospira Inc. is recalling 106,900 vials of Magnesium Sulfate Injection, USP, 50% because 12-month stability testing failed pH specifications.

    Product
    Magnesium Sulfate Injection, USP, 50%, 20mL, Single dose Fliptop Vial, For IV or IM use, Rx only, Manufactured by Hospira, Inc. 4285 Wesleyan Blvd Rocky Mount, NC 27804 for Hospira, Inc. 275 N Field Drive, Lake Forest, IL 60045. NDC 0409-2168-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1108-2015·2015-06-03

    Hospira Recalls Lactated Ringer's Irrigation Bags Due to Mold Contamination

    Hospira is recalling 24,744 bags of Lactated Ringer's Irrigation due to confirmed mold contamination. The product was distributed nationwide.

    Product
    LACTATED RINGER'S IRRIGATION, USP, 3000 mL flexible container bag, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7828-08.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1076-2015·2015-05-20

    Hospira Recalls Magnesium Sulfate Bags Due to Incorrect Barcodes

    Hospira is recalling 181,704 bags of Magnesium Sulfate in Dextrose because some units may have incorrect barcodes that scan as heparin sodium.

    Product
    MAGNESIUM SULFATE IN DEXTROSE — MAGNESIUM SULFATE IN DEXTROSE (MAGNESIUM SULFATE IN DEXTROSE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0976-2015·2015-05-13

    Hospira Recalls 0.9% Sodium Chloride Injection Due to Human Hair

    Hospira Inc. is recalling 9,912 units of 0.9% Sodium Chloride Injection, USP, 250 mL, because human hair was found floating in the IV solution.

    Product
    0.9% Sodium Chloride Injection, USP, 250 mL, Rx only, VisIV Container, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7983-25.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0973-2015·2015-05-06

    Hospira Recalls Ketorolac Tromethamine Injections Due to Crystallization

    Hospira is voluntarily recalling specific lots of Ketorolac Tromethamine Injections because of crystallization. The affected products were distributed nationwide, in Puerto Rico, and in Guam.

    Product
    Ketorolac Tromethamine Inj. USP, 60 mg (30 mg/mL), 2 mL Fill, Single-dose vial, Rx Only, Hospira Inc., Lake Forest, IL --- NDC 00409-3796-01 --- Also labeled under NOVAPLUS label NDC 00409-3796-49
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0972-2015·2015-05-06

    Hospira Recalls Ketorolac Tromethamine Injections Due to Crystallization

    Hospira Inc. is voluntarily recalling specific lots of Ketorolac Tromethamine Injection due to crystallization. The recall covers products distributed nationwide, in Puerto Rico, and in Guam.

    Product
    Ketorolac Tromethamine Inj. USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose vial, Rx Only, Hospira Inc., Lake Forest, IL --- NDC 00409-3795-01--- Also labeled under NOVAPLUS label NDC 00409-3795-49
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0969-2015·2015-04-29

    Hospira Recalls 0.9% Sodium Chloride Injection Due to Human Hair Particulate

    Hospira is recalling 0.9% Sodium Chloride Injection, USP, 250 mL, because a human hair was found sealed in the bag at the additive port area.

    Product
    0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0490-2015·2015-04-29

    Hospira Recalls Sodium Chloride Injection Due to Sterility Concerns

    Hospira Inc. is recalling 128,050 units of 0.9% Sodium Chloride Injection due to a potential leak at the administrative port that compromises sterility.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1517-2015·2015-04-29

    Hospira PCA 3 Infusion Pump Recalled for Door Design Flaw

    Hospira is recalling 8,214 PCA 3 infusion pumps because the clear plastic door design allows excessive flexing, permitting unauthorized access to medication vials.

    Product
    The PCA 3 infusion pump allows clinicians, or patients, to (self) Administer analgesia safely and effectively within clinician programmed limits.
    Category
    Medical Device
    Distribution
    53 states
  • HighFDA (Devices)·Z-1518-2015·2015-04-29

    Hospira LifeCare PCA Infusion System Recalled for Door Design Flaw

    Hospira is recalling 38,882 LifeCare PCA infusion systems because the clear plastic door design allows excessive flexing, permitting unauthorized access to medication vials.

    Product
    The LifeCare PCA infusion system with Hospira MedNet software allows clinicians, or patients, to (self) Administer analgesia within clinician programmed and/or hospital defined medication limits.
    Category
    Medical Device
    Distribution
    53 states
  • CriticalFDA (Drugs)·D-0433-2015·2015-04-15

    Hospira Recalls MitoXANTRONE Injection Due to Stability Failures

    Hospira Inc. is recalling MitoXANTRONE Injection vials because the product failed stability specifications, resulting in subpotent medication and out-of-specification impurities.

    Product
    MITOXANTRONE — MITOXANTRONE (MITOXANTRONE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0483-2015·2015-04-15

    Hospira Recalls Ketorolac Tromethamine Injections Due to Crystallization

    Hospira Inc. is voluntarily recalling specific lots of Ketorolac Tromethamine Injection due to crystallization. The recall covers vials distributed nationwide and internationally.

    Product
    KETOROLAC TROMETHAMINE — KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0482-2015·2015-04-15

    Hospira Recalls Ketorolac Tromethamine Injection Due to Crystallization

    Hospira Inc. is voluntarily recalling specific lots of Ketorolac Tromethamine Injection because of crystallization. The affected vials were distributed nationwide and in Guam and Singapore.

    Product
    KETOROLAC TROMETHAMINE — KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0417-2015·2015-03-25

    Hospira Recalls 5% Dextrose Injection Due to Sterility Concerns

    Hospira is recalling 94,440 bags of 5% Dextrose Injection due to a potential leak at the administrative port that compromises sterility.

    Product
    DEXTROSE — DEXTROSE (DEXTROSE MONOHYDRATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-1075-2015·2015-03-04

    Hospira Recalls Plum A+ Infusion Pumps Due to Alarm Failure

    Hospira is recalling 190 Plum A+ infusion pumps because their alarm assemblies may fail to sound at any volume level.

    Product
    The Plum A+ Infusion System is designed to meet the fluid delivery requirements of today's evolving healthcare environments. It is a cassette based multi-function infusion system. The Plum A+ allows two lines in and one line out. The pump can be used for standard, piggyback, or c
    Category
    Medical Device
    Distribution
    50 states
  • HighFDA (Devices)·Z-1071-2015·2015-03-04

    Hospira Recalls Plum A+ Infusion Pumps With Failing Alarm Assemblies

    Hospira Inc. is recalling 315 Plum A+ infusion pumps because one lot of alarm assemblies may fail to sound at all volume levels.

    Product
    The Plum A+ Infusion System is designed to meet the fluid delivery requirements of today's evolving healthcare environments. It is a cassette based multi-function infusion system. The Plum A+ allows two lines in and one line out. The pump can be used for standard, piggyback, or c
    Category
    Medical Device
    Distribution
    50 states

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

Hospira

American pharmaceutical company

Country
United States
Founded
2004
Parent company
Pfizer

Official website

Source: Wikidata (Q1470525), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.